China CDC weekly · 2026
National and Provincial Burden of Non-Communicable Diseases Attributable to High Alcohol Use - China, 1990-2023.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Yang, Li Teng, Zhao Zhenping, Zhou Maigeng
Аннотация
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Alcohol is a Group 1 carcinogen; in China, high alcohol use substantially contributes to the non-communicable diseases (NCDs) burden.
WHAT IS ADDED BY THIS REPORT?: From 1990-2023, age-standardized high alcohol use-attributable NCDs death and disability-adjusted life years (DALYs) rates declined markedly (-57.6%, -46.9%), while absolute numbers rose slightly (11.8%, 6.9%). In 2023, neoplasms led DALYs, followed by substance use disorders; diabetes and kidney diseases are smaller but rising (160.22%, 2010-2023). Sex disparity persists (male-to-female NCDs DALY ratio 10.64). Provincial and disease-specific burdens are linked.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: Prioritize substance use disorders and monitor rising diabetes and kidney diseases; continue reducing the neoplasms burden; tailor prevention by age, sex, region and cause.
WHAT IS ADDED BY THIS REPORT?: From 1990-2023, age-standardized high alcohol use-attributable NCDs death and disability-adjusted life years (DALYs) rates declined markedly (-57.6%, -46.9%), while absolute numbers rose slightly (11.8%, 6.9%). In 2023, neoplasms led DALYs, followed by substance use disorders; diabetes and kidney diseases are smaller but rising (160.22%, 2010-2023). Sex disparity persists (male-to-female NCDs DALY ratio 10.64). Provincial and disease-specific burdens are linked.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: Prioritize substance use disorders and monitor rising diabetes and kidney diseases; continue reducing the neoplasms burden; tailor prevention by age, sex, region and cause.